Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Facial Nerve Morbidity After Superficial Parotidectomy in the Absence of Nerve Conductor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04706052
Recruitment Status : Completed
First Posted : January 12, 2021
Last Update Posted : January 13, 2021
Sponsor:
Information provided by (Responsible Party):
Fazila Hashmi, Liaquat University of Medical & Health Sciences

Brief Summary:
In this single-centre, cross-sectional case series, the investigators aim to evaluate the incidence of facial nerve injury in patients undergoing superficial parotidectomy in the absence of nerve conductor. Data to be collected retrospectively from a prospectively maintained database of consecutive patients, at the Department of Surgery, Liaquat University of Medical and Health Sciences Jamshoro, Pakistan. The sample size was calculated as 101.

Condition or disease Intervention/treatment
Facial Nerve Injuries Adenoma, Pleomorphic Other: Superficial Parotidectomy

Detailed Description:
In this single-centre, cross-sectional case series, the investigators aim to evaluate the incidence of facial nerve injury in partcipants undergoing superficial parotidectomy in the absence of nerve conductor. The institutional Research Ethics Committee has approved the study. Data to be collected retrospectively from a prospectively maintained database, at the Department of Surgery, Liaquat University of Medical and Health Sciences Jamshoro, Pakistan. The data period to be over a period of nine years that is from 1st January 2012 till August 2020. The sample size was calculated using the WHO sample size calculator and taking disease prevalence as 7.1 with CI 95%, which turned out to be 101. All the patients with pleomorphic adenoma irrespective of age and gender were included. To control any chance of bias, one of the members of researchers as part of the team who operated upon these patients. The primary outcome was the incidence of temporary or permanent facial nerve injury, while secondary outcomes were wound infection, seroma, hematoma, Frey's syndrome, salivary fistula and disfigured scar. Temporary facial nerve injury was defined as a feature of facial nerve palsy with full recovery to regular activity within six months. Permanent facial nerve injury was defined as any facial nerve dysfunction lasting beyond six months of operation. The data was recorded on a predesigned Performa, and patients' confidentiality was maintained assigning codes to each case known only to researchers. The data was calculated using SPSS version 23. Values of mean and standard deviation were calculated for continuous variables, whereas frequencies were calculated for categorical data.

Layout table for study information
Study Type : Observational
Actual Enrollment : 101 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: Facial Nerve Morbidity After Superficial Parotidectomy in the Absence of Nerve Conductor: an Experience From a Low Resource Country
Actual Study Start Date : January 2012
Actual Primary Completion Date : August 2020
Actual Study Completion Date : January 2021

Group/Cohort Intervention/treatment
Superficial Parotidectomy Patient
All the patients with pleomorphic adenoma irrespective of age and gender who underwent Superficial parotidectomy
Other: Superficial Parotidectomy
Classical procedure for pleomorphic adenoma of the parotid gland is superficial parotidectomy around the world. This study only observed the outcome with reference to facial nerve morbidity




Primary Outcome Measures :
  1. incidence of temporary or permanent facial nerve injury [ Time Frame: 12 months ]
    Temporary facial nerve injury was defined as a feature of facial nerve palsy with full recovery to regular activity within six months. Permanent facial nerve injury was defined as any facial nerve dysfunction lasting beyond six months of operation.


Secondary Outcome Measures :
  1. wound infection [ Time Frame: 12 months ]
    Rate of postoperative surgical site infection will be calculated

  2. seroma [ Time Frame: 12 months ]
    Rate of postoperative formation of seroma (non-infected collection) occurring after superficial parotidectomy will be calculated

  3. hematoma [ Time Frame: 12 months ]
    Rate of postoperative incidence of hematoma/ clot formation at the operative site will be calculated

  4. Frey's syndrome [ Time Frame: 12 months ]
    Frey's syndrome is the result of misdirected regeneration of parasympathetic fibres connecting with regenerating sympathetic nerve leading to facial sweating and flushing during times of eating food. Rate of occurrence of Frey's syndrome will be calculated to understand its incidence.

  5. salivary fistula [ Time Frame: 12 months ]
    Salivary fistula is abnormal communication between skin and remaining gland. Its rate of occurrence will be calculated during postoperative period after superficial parotidectomy.

  6. disfigured scar [ Time Frame: 12 months ]
    The number of participants developing cosmetically bad scar will be notified and data calculated.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
All the suitable and selected patients consented for surgery with an explanation of procedure-related complications. Superficial parotidectomy was a standard surgical procedure for these selected patients with previously untreated pleomorphic adenoma.
Criteria

Inclusion Criteria:

  • All the patients with pleomorphic adenoma irrespective of age and gender were included

Exclusion Criteria:

  • Patients with recurrent disease or unwilling for participation were excluded

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04706052


Locations
Layout table for location information
Pakistan
Fazila Hashmi
Jāmshoro, Sindh, Pakistan
Sponsors and Collaborators
Liaquat University of Medical & Health Sciences
Investigators
Layout table for investigator information
Principal Investigator: Fazila Hashmi, FCPS Liaquat University of Medical and Health Sciences Jamshoro Pakistan
Publications:
Layout table for additonal information
Responsible Party: Fazila Hashmi, Assistant Professor, Liaquat University of Medical & Health Sciences
ClinicalTrials.gov Identifier: NCT04706052    
Other Study ID Numbers: LUMHS/REC/-12
First Posted: January 12, 2021    Key Record Dates
Last Update Posted: January 13, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Fazila Hashmi, Liaquat University of Medical & Health Sciences:
Superficial Parotidectomy
Facial Nerve Injuries
Adenoma, Pleomorphic
Additional relevant MeSH terms:
Layout table for MeSH terms
Adenoma
Adenoma, Pleomorphic
Facial Nerve Injuries
Facies
Disease Attributes
Pathologic Processes
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Facial Nerve Diseases
Mouth Diseases
Stomatognathic Diseases
Cranial Nerve Injuries
Cranial Nerve Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries
Neoplasms, Complex and Mixed